Credit Suisse (SIX:CSGN) analyst A.J. Rice maintained a Buy rating on Tenet Healthcare on Monday, setting a price target of $27, which is approximately 36.64% above the present share price of $19.76.
Rice expects Tenet Healthcare to post earnings per share (EPS) of $0.89 for the second quarter of 2020.
The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in Tenet Healthcare, with an average price target of $27.2.
The analysts price targets range from a high of $40 to a low of $20.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $4.52 billion and a net profit of $354 million. The company's market cap is $2.07 billion.
According to TipRanks.com, Credit Suisse analyst A.J. Rice is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 4.2% and a 55.00% success rate.
Tenet Healthcare Corp (NYSE:THC). engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.